We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $83.3B
1-Year Est. Return 31.19%
This Fund
S&P 500
This Quarter Est. Return
+11.39%
1 Year Est. Return
+31.19%
3 Year Est. Return
+75.49%
5 Year Est. Return
+99.03%
10 Year Est. Return
+295.58%
AUM
$66.3B
AUM Growth
+$6.83B
Cap. Flow
-$878M
Cap. Flow %
-1.32%
Top 10 Hldgs %
22.69%
Holding
1,623
New
157
Increased
524
Reduced
643
Closed
131

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$196M
2
WCN
Waste Connections
WCN
+$176M
3
MSFT icon
Microsoft
MSFT
+$173M
4
ROP icon
Roper Technologies
ROP
+$145M
5
CPRT icon
Copart
CPRT
+$129M

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$295M
2
TMO icon
Thermo Fisher Scientific
TMO
+$292M
3
TRI icon
Thomson Reuters
TRI
+$218M
4
KEYS icon
Keysight
KEYS
+$164M
5
ON icon
ON Semiconductor
ON
+$112M

Sector Composition

Rank Sector Weight
1 Financials 21.45%
2 Technology 19.78%
3 Industrials 13.23%
4 Healthcare 8.92%
5 Energy 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSTX
1451
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$45.4K ﹤0.01%
13,514
-2,400
-15% -$6.18K
KYNB
1452
Kyntra Bio
KYNB
$27.2M
$43.6K ﹤0.01%
1,970
-90
-4% -$1.36K
CLNE icon
1453
Clean Energy Fuels
CLNE
$427M
$43.1K ﹤0.01%
11,245
– –
NKTR icon
1454
Nektar Therapeutics
NKTR
$2.39B
$42.4K ﹤0.01%
+5,002
New +$37.9K
CNDT icon
1455
Conduent
CNDT
$244M
$40.7K ﹤0.01%
11,154
– –
CCO icon
1456
Clear Channel Outdoor Holdings
CCO
$1.23B
$40.5K ﹤0.01%
22,230
– –
SGMO
1457
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$40.1K ﹤0.01%
73,799
+31,003
+72% +$14.3K
ESPR
1458
DELISTED
Esperion Therapeutics
ESPR
$40K ﹤0.01%
13,391
-19,227
-59% -$24.9K
TVRD
1459
Tvardi Therapeutics
TVRD
$19.7M
$39.9K ﹤0.01%
1,491
+620
+71% +$25.7K
OPK icon
1460
Opko Health
OPK
$985M
$39K ﹤0.01%
25,843
– –
FCEL icon
1461
FuelCell Energy
FCEL
$1.73B
$38.8K ﹤0.01%
808
– –
MTTR
1462
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$38.3K ﹤0.01%
14,255
– –
VTNR
1463
DELISTED
Vertex Energy, Inc
VTNR
$38.1K ﹤0.01%
+11,238
New +$44.1K
FUBO icon
1464
FuboTV Inc
FUBO
$261M
$36.7K ﹤0.01%
963
– –
SPCE icon
1465
Virgin Galactic
SPCE
$328M
$36.6K ﹤0.01%
747
– –
CYH icon
1466
Community Health Systems
CYH
$393M
$35.4K ﹤0.01%
11,311
-35,767
-76% -$96.4K
CTEV
1467
Claritev Corp
CTEV
$387M
$35.2K ﹤0.01%
612
– –
TDUP icon
1468
ThredUp
TDUP
$746M
$34.7K ﹤0.01%
+15,412
New +$40.1K
NKLA
1469
DELISTED
Nikola Corporation Common Stock
NKLA
$33.1K ﹤0.01%
1,262
– –
DHX icon
1470
DHI Group
DHX
$182M
$32.2K ﹤0.01%
12,418
– –
SPRO icon
1471
Spero Therapeutics
SPRO
$67.7M
$31.5K ﹤0.01%
21,462
+4,264
+25% +$5.08K
QVCGA
1472
DELISTED
QVC Group Inc Series A
QVCGA
$30.5K ﹤0.01%
+697
New +$23.9K
CTMX icon
1473
CytomX Therapeutics
CTMX
$675M
$30.5K ﹤0.01%
19,679
+4,042
+26% +$5.32K
MVIS icon
1474
Microvision
MVIS
$93.2M
$29K ﹤0.01%
10,917
– –
AKBA icon
1475
Akebia Therapeutics
AKBA
$354M
$28.7K ﹤0.01%
23,159
+6,330
+38% +$6.46K
57 58
59
60 61

Similar funds

Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Mackenzie Financial's Q4 2023 Portfolio in Review

As of Q4 2023, Mackenzie Financial held 1,623 positions worth $66.3B, up 11% from $59.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Mackenzie Financial's Q4 2023 filing shows 157 new, 524 increased, 643 reduced and 131 closed positions. Its largest new stake was Transmedics: 453,615 shares worth $35.8M. The largest sale was Amphenol, an estimated $295M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q4 2023 buy was Transmedics: 453,615 shares worth $35.8M.
  • Mackenzie Financial added most to PepsiCo in Q4 2023, an estimated $196M increase.
  • Mackenzie Financial's biggest Q4 2023 reduction was Amphenol, cutting an estimated $295M.
  • Mackenzie Financial fully exited Carter's in Q4 2023, selling an estimated $24.9M.
  • Mackenzie Financial's ten largest holdings make up 23% of its $66.3B portfolio in Q4 2023.
  • Mackenzie Financial opened 157 new positions and closed 131 in Q4 2023.
  • Mackenzie Financial's portfolio value rose 11% quarter-over-quarter to $66.3B.

Based on Mackenzie Financial's 13F filing for Q4 2023, filed 30 Jan 2024.